• Wed news: Novo and Viking heat up MASH space. New Pfizer R&D chief. Trump and the Biosecure Act. Sage Huntington’s prospect flunks trial. Dr. Oz to run CMS. See more on our front page


Metabolics Call









It's been a little over a year since the CV division was let go..Don't think for a second the same won't happen to us before the end of 2014... Androgel is slumping and Synthroid can hold its own without us
 












Move head count. Hire quintiles. Long time DMs bailing to other franchises. Alabama DM gone. Use interim DM's. these are the right things to do for the company and right out of Jduf play book. But make no mistake they know exactly the spot we r in. Good rms already telling leadership to be "open" to other ops. Get your good people to other franchises. Trust me.